Skip to content

Clinical trials

Mood Disorders trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mood Disorders Country / region: United Kingdom Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20082
20121
20151
20172
20181
20191
20201
20211
20221
20232
20241
20253
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Recruiting7
Not yet recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Oxford6
Eli Lilly and Company2
King's College London2
Takeda2
Activ'inside1
Imperial College London1
Medical Research Council Cognition and Brain Sciences Unit1
Parnassia Groep1
Queen Margaret University1
Rotherham Doncaster and South Humber NHS Foundation Trust1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mood Disorders20
Depressive Disorder12
Mental Disorders7
Major Depressive Disorder6
Anxiety Disorders4
Bipolar Disorder3
Depressive Disorder, Treatment-Resistant2
Psychotic Disorders2
Schizophrenia2
Anhedonia1

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.